Positives

• Temazepam is FDA-labeled for short-term insomnia (typically 7 to 10 days), and many sleep-onset and sleep-maintenance issues respond Mayo Clinic.
• Patients describe a noticeable rebound in deep sleep duration on temazepam compared with non-benzo sleep aids NIH StatPearls.

Negatives

• Tolerance can build within roughly three days of regular use, increasing the risk of physical dependence with chronic dosing FDA.
• Withdrawal can include rebound insomnia, agitation, twitching, hypersensitivity to light, and depersonalization MedlinePlus.

Hurdles & Side Effects

• Cognitive impact and long-term dependence concerns emerge as common themes in ME/CFS and neurological Long COVID discussions Mayo Clinic Connect.
• Patients emphasize the necessity for careful dosing management given the sensitivity profiles of chronic illness populations Mayo Clinic Connect.